Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the test AML Risk Stratification Gene Panel is 14 days.

What are the prerequisites for the test AML Risk Stratification Gene Panel

  • Patients must have a confirmed diagnosis of Acute Myeloid Leukemia (AML)
  • Patient must have a sufficient amount of bone marrow or blood sample for testing
  • Patient must not have any contraindications to undergoing genetic testing

What are the measure values for the test AML Risk Stratification Gene Panel

Gene Panel Measure Values
FLT3-ITD Positive/Negative
NPM1 Mutated/Normal
CEBPA Mutated/Normal
DNMT3A Mutated/Normal
IDH1 Mutated/Normal

What does this test AML Risk Stratification Gene Panel identify?

  1. FLT3: mutations in this gene are associated with poor prognosis in AML
  2. NPM1: mutations in this gene are associated with favorable prognosis in AML
  3. CEBPA: mutations in this gene are associated with intermediate prognosis in AML
  4. DNMT3A: mutations in this gene are associated with poor prognosis in AML

Why is this test AML Risk Stratification Gene Panel taken?

Test Name: AML Risk Stratification Gene Panel

Reason for Test:

  • To identify specific genetic mutations associated with Acute Myeloid Leukemia (AML)
  • To classify AML patients into different risk groups based on their genetic profile
  • To guide treatment decisions and predict prognosis in AML patients
  • To monitor disease progression and response to therapy

No FAQs available.

Customer Google Rating